Skip to main content
Premium Trial:

Request an Annual Quote

US Army Awards ADA $70K to Develop 'Lab-on-a-Chip' Technology

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ADA Technologies today announced it has received a $70,000 contract from the US Army to develop a "lab-on-a-chip" technology to identify biological hazards in complex matrices.

The contract is for Phase 1 research into the development of the sampling platform, which will be used to identify hazards such as toxins, viruses, vegetative bacteria, and spores in matrices including blood, soil, food, and water.

In a statement, ADA Chief Technology Officer Steven Arzberger said that currently, highly trained laboratory personnel need to perform multiple separate steps on large sample sizes to obtain enough material for biological hazard analysis and identification.

"ADA's lab-on-a-chip not only saves time, but improves efficiency because it can be carried out by virtually anyone, regardless of training level," he said.

ADA is a technology development and commercialization firm based in Littleton, Colo. It received a $1.15 million grant from the National Institutes of Health two years ago to develop an analytical tool for analyzing carbohydrate-protein interactions in drug discovery and diagnostics research.

In late 2008, the National Cancer Institute gave ADA a $149,121 grant to develop a nanotechnology-based imaging and sensing platform for discovering cancer biomarkers.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.